Biokin’s Iza-Bren Shows Strengths In IO Combos, First In SCLC

 
• By Dexter Jie Yan
  
Iza-Bren combined with PD-(L)1 agents have shown great potentials. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D